159 related articles for article (PubMed ID: 22713149)
1. Immune mechanisms in angiotensin II-induced target-organ damage.
Luft FC; Dechend R; Müller DN
Ann Med; 2012 Jun; 44 Suppl 1():S49-54. PubMed ID: 22713149
[TBL] [Abstract][Full Text] [Related]
2. Immune-related effects in hypertension and target-organ damage.
Muller DN; Kvakan H; Luft FC
Curr Opin Nephrol Hypertens; 2011 Mar; 20(2):113-7. PubMed ID: 21245763
[TBL] [Abstract][Full Text] [Related]
3. The interplay between Angiotensin II, TLR4 and hypertension.
Biancardi VC; Bomfim GF; Reis WL; Al-Gassimi S; Nunes KP
Pharmacol Res; 2017 Jun; 120():88-96. PubMed ID: 28330785
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the renin-angiotensin system and target organ protection.
Iwanami J; Mogi M; Iwai M; Horiuchi M
Hypertens Res; 2009 Apr; 32(4):229-37. PubMed ID: 19262496
[TBL] [Abstract][Full Text] [Related]
5. The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases.
Ruiz-Ortega M; Esteban V; Egido J
Trends Cardiovasc Med; 2007 Jan; 17(1):19-25. PubMed ID: 17210474
[TBL] [Abstract][Full Text] [Related]
6. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
[TBL] [Abstract][Full Text] [Related]
8. Novel role for inhibitor of differentiation 2 in the genesis of angiotensin II-induced hypertension.
Gratze P; Dechend R; Stocker C; Park JK; Feldt S; Shagdarsuren E; Wellner M; Gueler F; Rong S; Gross V; Obst M; Plehm R; Alenina N; Zenclussen A; Titze J; Small K; Yokota Y; Zenke M; Luft FC; Muller DN
Circulation; 2008 May; 117(20):2645-56. PubMed ID: 18474814
[TBL] [Abstract][Full Text] [Related]
9. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy].
Castro-Chaves P; Leite-Moreira AF
Rev Port Cardiol; 2004 May; 23 Suppl 2():II61-77. PubMed ID: 15222251
[TBL] [Abstract][Full Text] [Related]
10. Renal mechanisms of angiotensin II-induced hypertension.
Granger JP; Schnackenberg CG
Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms for the clinical benefits of angiotensin II receptor blockers.
Schmieder RE
Am J Hypertens; 2005 May; 18(5 Pt 1):720-30. PubMed ID: 15882557
[TBL] [Abstract][Full Text] [Related]
12. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
14. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease.
Loghman-Adham M; Soto CE; Inagami T; Cassis L
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F775-88. PubMed ID: 15187005
[TBL] [Abstract][Full Text] [Related]
15. Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders.
Fyhrquist F; Metsärinne K; Tikkanen I
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S19-24. PubMed ID: 8583476
[TBL] [Abstract][Full Text] [Related]
16. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases.
Kim S; Iwao H
Pharmacol Rev; 2000 Mar; 52(1):11-34. PubMed ID: 10699153
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells.
Esteban V; Ruperez M; Sánchez-López E; Rodríguez-Vita J; Lorenzo O; Demaegdt H; Vanderheyden P; Egido J; Ruiz-Ortega M
Circ Res; 2005 May; 96(9):965-73. PubMed ID: 15831814
[TBL] [Abstract][Full Text] [Related]
18. Vaccines in the management of hypertension.
Do TH; Chen Y; Nguyen VT; Phisitkul S
Expert Opin Biol Ther; 2010 Jul; 10(7):1077-87. PubMed ID: 20455790
[TBL] [Abstract][Full Text] [Related]
19. Role of the renin-angiotensin system in vascular inflammation.
Marchesi C; Paradis P; Schiffrin EL
Trends Pharmacol Sci; 2008 Jul; 29(7):367-74. PubMed ID: 18579222
[TBL] [Abstract][Full Text] [Related]
20. A new look at the renin-angiotensin system--focusing on the vascular system.
Nguyen Dinh Cat A; Touyz RM
Peptides; 2011 Oct; 32(10):2141-50. PubMed ID: 21945916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
